A heparin-binding protein was isolated from bovine uteri and purified to homogeneity. 
INTRODUCTION
Mainly owing to the work of the groups of Karnovsky, Castellot and Rosenberg, it is now generally established that heparin inhibits smooth-muscle cell (SMC) proliferation in vitro and in vivo [1] [2] [3] [4] [5] . Since SMC proliferation is regarded as one of the key events in the pathogenesis of atherosclerosis [6] , this inhibitory heparin effect is considered to be of great physiological and pathological significance. On the basis of these findings a model for the pathogenesis of atherosclerosis has been proposed [7] .
The molecular basis of this inhibitory heparin effect is not yet clear. Recently it has been suggested that heparin acts intracellularly after uptake by SMC [8, 9] . There are also data indicating that the interaction of heparin with SMC is receptor mediated [9, 10] . SMC migration can be specifically inhibited by heparin in a dose-dependent, cellspecific and reversible fashion [11] . The effect of heparin on SMC seems to be selective for certain heparin-ligand structures [12] .
To study the anti-proliferative heparin effect on SMC growth at a molecular level, i-t is necessary to isolate the SMC surface protein which is responsible for the binding of heparin. Recently, the isolation of a heparin-binding 38 kDa protein from tissue-cultured SMC-conditioned medium has been described [13] . This protein is specifically expressed by nodular SMC [14] . It is not clear, however, whether this protein, which is secreted by SMC and is not cell-associated, is involved in growth inhibition by heparin or whether it is just a marker protein for a nodular SMC phenotype.
The heparin effect is restricted to a certain phenotype of SMC. Cells from later passages or from cultures which were grown at 10 % (or more) fetal-calf serum apparently are not growth inhibited by heparin. It may be that the cellular binding protein which promotes the antiproliferative effect to the cell is only expressed by a particular SMC phenotype which is not the common cellular form of SMC from mass cultures. For this reason we did not use cultured SMC as a source for the isolation of the heparin-binding protein.
In the work presented here, we describe the isolation and partial characterization of a heparin-binding protein with a molecular mass of approx. 78 kDa from bovine uteri. This protein does not bind to other glycosaminoglycans. From SMC proliferation assays in vitro with affinity-purified antibodies from goat anti-serum or with monoclonal antibodies (mAbs) we suggest that this protein is involved in SMC growth inhibition.
MATERIALS AND METHODS Materials
The following materials were used for this study:
I5 To produce conventional anti-sera, 500 ug of protein in 500 ,u of phosphate-buffered saline (PBS) were mixed with the same volume of complete Freund's adjuvant and injected intracutaneously 3 times into rabbits or goats with 14 days between each injection. Anti-sera were produced by coagulation of blood. For affinity purification of the goat antibodies, 10 ml portions of anti-serum were applied to a 78 kDa protein-Sepharose CL-6B column (1.5 cm x 4 cm; approx. 2 mg of protein/ ml of gel). The column was washed with 120 ml of PBS and the bound antibodies were then eluted with 0.1 MTris/HCl/4 M-guanidinium chloride (pH 7.2). The antibody fraction in the eluate, as determined by 280 mm absorption, was collected, dialysed against 3 x 10 1 of water, and freeze-dried.
Fab fragments were produced by papain digestion following a standard protocol [15] EJl.i.s.a. assays were performed following a standard procedure [17] . Plates were coated with 1 ,sg of protein/ ml of PBS. All further washing and incubation procedures, with the exception of the final colour reaction, were carried out by using 1 % bovine serum albumin (BSA) in PBS. In those cases when whole cells were used in the e.l.i.s.a. procedure, 1000 SMC were seeded in each well, cultured for 24 h, washed with PBS 3 times, fixed with methanol at room temperature for 10 min and further processed according to the routine standard e.l.i.s.a. procedure.
For Western blot analysis, proteins were separated on SDS/PAGE and subsequently transferred to nitrocellulose as described by Towbin et al. [18] . Specific staining with antibodies was performed as previously described [19] . Positive control experiments for the antiserum against the band 4.1 were carried out with erythrocyte ghosts as protein source. mAb W6/32 was from a preparation described previously [20] . Indirect immunofluorescence was performed as described previously [17,2 1] . Stained cells were examined by a cytofluorograph (Ortho Diagnostic Systems, Westwood, MA, U.S.A.).
Cell-surface iodination and immunoprecipitation
Membrane proteins of the established human colon carcinoma cell line HT-29 were radiolabelled by the lactoperoxidase method described by Goding [22] . In brief, 1 x 107 cells (viability over 95 %), suspended in 0.5 ml of PBS, were labelled with 0.5 mCi of 125I in the presence of 10,ug of lactoperoxidase. To this mixture 10 je each of 0.003 % H202 in PBS, 0.01 % H202 in PBS and 0.03 % H202 in PBS were added (1 min between each step). The reaction was stopped by adding 500,1 of 5 mM-NaI in PBS at 4°C and mixing. Cells were washed three times by centrifugation at 1000 g and resuspension in PBS, and then were solubilized in 1 % Nonidet P-40/ 1988 832 10 mM-Tris/HCl/ 150 mM-NaCl/ 10 gM-PMSF/ 10 uMaprotinin (pH 7.2) at 4 'C. Nuclei and cell debris were removed by centrifugation at 10000 g and the proteins in the supernatant were non-specifically precipitated by incubation with 100 4u1 of a 1:1 (v/v) suspension of Protein A-Sepharose in the above-mentioned lysis buffer for 1 h at 4 Sepharose gels were exhaustively washed with water, suspended in twice the volume of water, and adjusted to pH 10-11 with 2 M-NaOH. CNBr (50 mg/ml) was added to the gel and the pH maintained between 10 and 11 by adding 2 M-NaOH dropwise. After 3 min of reaction, the gel was washed extensively with 0.2 M-sodium acetate. Ligand (2-5 mg of heparin or protein/ml of gel) in 0.1 Msodium acetate was added and the mixture was shaken at 4 'C for 24 h, after which period, 50 ,tl of ethanolamine/ ml of gel was added. Shaking was continued for 5 h and the gel was then washed with 4 M-NaCl and PBS.
Isolation of the heparin-binding protein All isolation procedures were carried out at 0-4 'C. Ten bovine uteri from the slaughter house were rapidly cooled to 0 'C. Blood vessels, ligamentae, mucus, fasciae, etc., were removed and the uteri were then minced, suspended in approx. the same volume of 2 mM-PMSF/ 2 mM-EDTA in PBS and homogenized with a spinning knife (Star-Mix) at 0 'C. The homogenate was frozen, thawed, and centrifuged at 10000 g and 0 'C for 15 min. To show enrichment of the heparin-binding protein in the microsomes, the supernatant was recentrifuged at 100000 g (60 TI rotor, Beckman L5 ultra-centrifuge) and The 10000 g supernatant from uterus homogenate was adjusted to 0.1 M-Tris/HCI/0.1% Chaps/I mM-PMSF/ 1 mM-EDTA, pH 7.85 (elution buffer), and applied to the top of a heparin-Sepharose CI-6B column (50 ml). The column was washed with 500 ml of the elution buffer and further eluted with a linear gradient (500 ml + 500 ml) of elution buffer and elution buffer+1 M-NaCl. Fractions were assayed for 280 nm absorption, pooled as indicated, and investigated on SDS/PAGE. Electrophoresis of the pooled fraction is shown.
the microsomal pellet, suspended in 0.1 M-Tris/HCI/ 0.1 % Chaps/I mM-PMSF/ 1 mM-EDTA, pH 7.85, then used as a source for further processing. In most cases, however, the 10000 g supernatant was directly used. The supernatant was adjusted to pH 7.85 with 2 MTris, and applied to a heparin-Sepharose CL-6B column (50 ml, 2.5 cm x 10 cm). The column was then washed with ice-cold 0.1 M-Tris/HCl/0.1 % Chaps/I mm-PMSF/1 mM-EDTA, pH 7.85 (elution buffer), until the 280 nm absorption baseline was reached. Elution was continued with a gradient (500 + 500 ml) of elution buffer and 1 M-NaCl + elution buffer. Fractions of 50 ml were collected at 200 ml/h. Portions (200 ,1) were adjusted to 80 % ethanol and incubated at 4°C for 5 h. After centrifugation at 10000 g the precipitates were solubilized in 50 ,ul of SDS sample buffer and subjected to SDS/PAGE. Fractions were pooled as indicated in Fig. 1 , concentrated 5:1 by distillation in vacuo and chromatographed in portions on Sepharose CL-6B (5 cm x 100 cm) with 0.5 M-NaCl/0.1 M-Tris/HCl/0. I % Chaps/i mM-PMSF/1 mM-EDTA, pH 7.4, as eluant. Fractions of 20 ml were collected at 200 ml/h, analysed for 280 nm absorption, pooled as indicated in Fig. 2(a) , diluted 1: 5 with water and adsorbed onto 20 ml of heparin-Sepharose (1.6 cm x 10 cm). The column was washed with 100 ml of 0.1 M-Tris/HCl/0.1 % Chaps/ 1 mM-PMSF/ 1 mM-EDTA, pH 7.85, and the protein was eluted with 50 ml of the same buffer+ 1 M-NaCl. The protein peak, determined by 280 nm absorption, was collected, concentrated 3: 1 by distillation in vacuo and chromatographed on Sephacryl S-300 (2 cm x 100 cm) with 0.5 M-NaCl/0.1 M-Tris/HCl/0. Binding assays with the heparin-binding protein Heparin, dextran sulphate, chondroitin sulphate, dermatan sulphate and keratan sulphate were adjusted to concentrations of between 0.5 ,ug/ml and 5 mg/ml in 10 ml of 1 mM-EDTA/0.1 % BSA/0.1 % Chaps in PBS (basic buffer) and applied to a heparin-binding proteinSepharose CL-6B column (1 ml; 0.5 cm x 5 cm, approx. 2 mg of protein). The column was washed with 10 ml of the basic buffer and the bound substances were desorbed with 1 M-NaCl in PBS. The polysaccharide content in the unbound and in the bound material was determined by the orcinol reaction [26] with the same polysaccharide, at various concentrations, as standard.
In another experiment, 100 ng of basement-membrane heparan [35S]sulphate [25] or 100 ng of endothelial-cell surface heparan [35S]sulphate [27] (based on the amount of GlcN in the hydrolysate) was applied to the same heparin-binding protein column as described above. The column was first washed with 5 ml of basic buffer and then eluted with a linear gradient (10 ml + 10 ml) of basic buffer and basic buffer + 0.5 M-NaCl. Fractions of 500 ,1
were collected and assayed for 35S radioactivity.
RESULTS
Isolation and partial characterization of the heparinbinding protein from bovine uteri All isolation procedures were carried out at 0-4 'C in the presence of 0.1 % Chaps and protease inhibitors 1 mM-PMSF and 1 mM-EDTA.
Microsomes or the microsomal supernatant (10000 g supernatant) from bovine uteri were chromatographed (Fig. 1) . Both proteins were co-enriched in all further purification procedures, which involved chromatography on Sepharose CL-6B (Fig. 2a) and Sephacryl S-300 (Fig. 2b) .
As shown in Fig. 3, section 1 , for the intact heparinbinding molecule and in Fig. 3 (Fig. 3, section 3) . Again, both protein bands were stained with mAb 38/87. No band of higher molecular mass was detected in the Western blot analysis indicating that the 78 kDa protein is not a breakdown product of higher molecular mass compounds.
There is evidence to suggest that the protein is located on the cell surface from immunoprecipitation of surfaceradioiodinated HT-29 (human carcinoma cell line) cell lysates (Fig. 4) . A band of 78 kDa was precipitated by mAb 38/87. As negative controls, we used mAb 45/11, which did not cross-react to human species and an mAb against HLA class I antigen. Some lower molecular mass proteins were also unspecifically absorbed to the Protein A-Sepharose immunocomplex when using mAb 38/87 and control antibodies.
The molecule has some striking similarities to erythrocyte protein 4.1 as indicated by molecular mass, staining pattern on endothelial cells and SMC and susceptibility to proteolytic degradation. Analogues of this erythrocyte submembraneous skeleton protein have recently been described for lymphocytes [28] , fibroblasts [29] and endothelial cells [30, 31] . In Western blot analysis with an anti-serum against bovine band 4.1 from a preparation described previously ( [30] buffers. The amino acid composition is given in Table 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . but also heparin binds to the protein with a higher affinity than other related polyanions. In order to select the conditions which allow discrimination between non-specific and specific interactions we chose the following conditions for binding assays with heparin: (1) pH higher than 7.0; (2) presence of other proteins (BSA) and detergents (Chaps); (3) presence of chelating agents (EDTA). For binding assays with heparin and various other polyanions we constructed a 78 kDa protein-Sepharose CL-2B column. The polyanions were applied in 10 ml portions and at various concentrations and were measured in the eluate by the orcinol reaction.
Under these conditions we determined a saturable heparin-binding characteristic (Fig. 5) . We did not observe binding in any of the other common glycosaminoglycans from mammalian tissue. Dextran sulphate, a polyanion which does not occur physiologically, binds to the 78 kDa protein in a nonsaturable fashion (Fig. 5) .
The binding of the 78 kDa protein to polyanions is not only selective to heparin over other glycosaminoglycans but also has a binding specificity to certain heparan sulphate structures. A basement-membrane proteoheparan sulphate from HR-9 cells and a cell-surface proteoheparan sulphate from bovine aortic endothelial cells were first applied to a 78 kDa protein column and then desorbed with a linear gradient of 0-0.5 M-NaCl (Fig. 6 ). There is a much stronger affinity of the basementmembrane component compared with the cell-surface proteoheparan sulphate from bovine aortic endothelial cells. Localization of the 78 kDa protein Affinity-purified goat antibodies and mAbs against the 78 kDa protein were used to investigate the localization of this protein in tissues and cells by histo-immunofluorescence. This protein seems to be widely distributed on endothelial and epithelial cells as well as on skeleton muscle and SMC (Fig. 7) . From the staining pattern we conclude that the 78 kDa protein is either located on the cell surface or approximate to it. As two examples we show immunofluorescent staining with conventional goat antibodies on skeleton muscle and on tissue-cultured SMC. Since the human T leukaemia cell line Jurkat did not react with mAb 38/87 against the heparin-binding molecule in cytofluorographic analysis (Fig. 8) , we presume that this antigen is not present on blood cells. This result also underlines the dissimilarity to band 4.1. In contrast, the human colon carcinoma cell line HT-29 [33] , gave a strong fluorescence staining with mAb 38/87 (Fig. 8) . Cell line HT-29 shows some variety in intensity of fluorescence after labelling with mAb 38/87. This may point either to heterogeneity within the cell population or to cell-cycle dependence of antigen expression. In the same assay mAb 13/83 did not stain HT-29 cells or Jurkat cells. Reaction of SMC with anti-78 kDa antibodies SMC were seeded in e.l.i.s.a. plates and the titre of affinity-purified goat antibodies was determined in comparison with 78 kDa protein-coated wells. As shown in Fig. 9 , there are parallel titres against the 78 kDa protein and the tissue-cultured SMC. SMC were grown to confluence (approx. 50000 cells/cm2) and digested with heparinase for 90 min to remove bound heparan sulphate. Cells were then incubated with 50 ng of a basement-membrane proteoheparan [35S] sulphate from a preparation described previously [25] in the absence or presence of affinity-purified goat antibodies or mAbs against the 78 kDa protein. As shown in Fig. 10 The cell layer was washed, dissolved, and assayed for radioactivity.
The 78 kDa protein is widely distributed and not only present on SMC. From our histo-immunological investigations its seems to be present in all cells which grow associated to basement-membrane structures. Furthermore, basement-membrane proteoheparan sulphate from HR-9 cells [25] binds to the 78 kDa protein with a much higher affinity than endothelial cell-surface proteoheparan sulphate from another preparation [27] . Both proteoheparan sulphates are eluted from DEAESephacel with the same ionic strength. Inhibition studies with the same proteoheparan sulphates show that only the basement-membrane components have an inhibitory effect on SMC at polysaccharide concentrations of 100 ,tg/ml. On the basis of these findings, it is possible that the 78 kDa protein belongs to a group of cellmembrane proteins which promote binding of cells to basement-membrane molecules [36, 37] , and in this particular case, to basement-membrane proteoheparan sulphate. Therefore, the anti-proliferative effect of heparin on the proliferation of SMC may eventually be one phenomenon within the modulating effects of extracellular matrix [38, 39] on cell behaviour and cellular phenotype.
One reason for the heparin effect on SMC proliferation gaining so much attention from other scientists, is that it offers the possibility of treating diseases which are The proliferation assay was performed according to Castellot et al. [4] . SMC were converted into a growtharrested state by culturing with 0.5 % fetal-calf serum (low serum) for 3 days. Some of the SMC cultures were maintained in low serum (low-serum control). To the other SMC cultures medium with 20% serum (high serum) was added in the absence (high-serum control) or presence of lOO,ug heparin/ml (a), affinity-purified goat anti-78 kDa protein antibodies (b), Fab fragments of these antibodies (c), mAb 38/87 (d), mAb 13/83 (e) (5,ug/ml each), 100 ,ug of basement-membrane heparan sulphate from HR-9 cells/ml (j) or 100 jug of cell-surface heparan sulphate from bovine aortic endothelial cells/ml (g). Cells
were cultured for 3 days and counted. High-serum control cell numbers were set as 0 % inhibition and low-serum control cell numbers as 100% inhibition. Standard goat IgG or standard mouse IgG in concentrations of 5 #g/ml were added to high-serum cultures as a negative control.
accompanied by SMC growth and change in phenotype with a non-anticoagulant heparin fraction. The purification of a heparin-binding protein involved in SMC growth inhibition, as described here, allows study of the interaction between heparin and the SMC surface on a molecular level. The isolation procedure of the antithrombin III binding fragment [40] offers the opportunity to construct affinity matrices for the isolation of the heparin oligosaccharide responsible for the inhibition of SMC proliferation.
